ARTV vs GD · $37.3M cap vs P/E 22, rev $52.55B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
ARTV currently screens at market cap $37.3M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the ARTV and GD stock pages for the full models.
Not investment advice.